Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee
Clinical trial NCT03291470 · COMPLETED
Trial details
- NCT number
- NCT03291470
- Sponsor
- Kolon TissueGene, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2024-03-06
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.